A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease

NCT00059280 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Glycogen Storage Disease Type II

Interventions

BIOLOGICAL: Myozyme

Sponsor

Genzyme, a Sanofi Company